UFP Technologies Correlations
UFPT Stock | USD 314.41 3.14 1.01% |
The current 90-days correlation between UFP Technologies and iRhythm Technologies is 0.12 (i.e., Average diversification). The correlation of UFP Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
UFP Technologies Correlation With Market
Very weak diversification
The correlation between UFP Technologies and DJI is 0.45 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding UFP Technologies and DJI in the same portfolio, assuming nothing else is changed.
UFP |
Moving together with UFP Stock
Moving against UFP Stock
0.43 | VMD | Viemed Healthcare | PairCorr |
0.5 | KZR | Kezar Life Sciences | PairCorr |
0.34 | EWTX | Edgewise Therapeutics | PairCorr |
0.32 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between UFP Stock performing well and UFP Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze UFP Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
KIDS | 2.55 | (0.32) | 0.00 | (0.11) | 0.00 | 5.04 | 19.39 | |||
IRTC | 2.82 | 0.02 | 0.01 | 0.14 | 2.95 | 5.63 | 26.19 | |||
NPCE | 3.51 | 0.32 | 0.14 | 0.25 | 3.00 | 9.73 | 35.38 | |||
HSKA | 1.18 | 0.59 | 0.82 | 15.69 | 0.00 | 3.63 | 21.36 | |||
ELMD | 2.60 | 0.91 | 0.31 | 0.98 | 2.15 | 6.65 | 13.47 | |||
VREX | 2.39 | 0.47 | 0.15 | 0.53 | 2.69 | 7.07 | 18.78 | |||
SGHT | 3.18 | (1.03) | 0.00 | (0.18) | 0.00 | 6.96 | 18.22 | |||
APYX | 3.24 | 0.17 | 0.04 | 0.30 | 3.27 | 9.38 | 32.02 | |||
SIBN | 3.00 | (0.44) | 0.00 | (0.09) | 0.00 | 6.75 | 27.00 | |||
IRMD | 1.61 | 0.08 | 0.08 | 0.17 | 1.69 | 3.26 | 11.03 |
UFP Technologies Corporate Management
Mitchell Rock | Sr. VP of Sales and Marketing | Profile | |
Steven Cardin | VP MedTech | Profile | |
Jason Holt | Chief Officer | Profile | |
Christopher Esq | Secretary Counsel | Profile |